AU2001232079A1 - Water dispersible formulation of paroxetine - Google Patents

Water dispersible formulation of paroxetine

Info

Publication number
AU2001232079A1
AU2001232079A1 AU2001232079A AU2001232079A AU2001232079A1 AU 2001232079 A1 AU2001232079 A1 AU 2001232079A1 AU 2001232079 A AU2001232079 A AU 2001232079A AU 2001232079 A AU2001232079 A AU 2001232079A AU 2001232079 A1 AU2001232079 A1 AU 2001232079A1
Authority
AU
Australia
Prior art keywords
paroxetine
water dispersible
dispersible formulation
formulation
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001232079A
Other versions
AU2001232079B2 (en
Inventor
Ahmad Khalaf Al-Deeb Al-Ghazawi
David Philip Elder
Padma Meneaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0003232.6A external-priority patent/GB0003232D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2001232079A1 publication Critical patent/AU2001232079A1/en
Application granted granted Critical
Publication of AU2001232079B2 publication Critical patent/AU2001232079B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001232079A 2000-02-11 2001-02-09 Water dispersible formulation of paroxetine Ceased AU2001232079B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0003232.6 2000-02-11
GBGB0003232.6A GB0003232D0 (en) 2000-02-11 2000-02-11 Novel composition
PCT/GB2001/000569 WO2001058449A1 (en) 2000-02-11 2001-02-09 Water dispersible formulation of paroxetine

Publications (2)

Publication Number Publication Date
AU2001232079A1 true AU2001232079A1 (en) 2001-11-01
AU2001232079B2 AU2001232079B2 (en) 2004-11-25

Family

ID=9885464

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001232079A Ceased AU2001232079B2 (en) 2000-02-11 2001-02-09 Water dispersible formulation of paroxetine
AU3207901A Pending AU3207901A (en) 2000-02-11 2001-02-09 Water dispersible formulation of paroxetine

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU3207901A Pending AU3207901A (en) 2000-02-11 2001-02-09 Water dispersible formulation of paroxetine

Country Status (8)

Country Link
US (1) US20030186938A1 (en)
EP (1) EP1255549A1 (en)
AU (2) AU2001232079B2 (en)
CA (1) CA2399411A1 (en)
GB (1) GB0003232D0 (en)
HK (1) HK1051486A1 (en)
NO (1) NO20023785L (en)
WO (1) WO2001058449A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK200100341A (en) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Process for the preparation of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
WO2003013470A1 (en) * 2001-08-09 2003-02-20 Smithkline Beecham Plc. Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt
EP1791531A1 (en) * 2004-08-20 2007-06-06 Alpharma, Inc. Paroxetine formulations
EP2026787B1 (en) * 2006-05-13 2013-12-25 Novo Nordisk A/S Tablet formulation comprising repaglinide and metformin
US20100016322A1 (en) * 2007-02-28 2010-01-21 Nagesh Nagaraju Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same
CN102631329A (en) * 2012-04-12 2012-08-15 无锡万全医药技术有限公司 Oral paroxetine disintegrating tablet and preparation process thereof
CN104382870A (en) * 2014-10-30 2015-03-04 万全万特制药江苏有限公司 Compound containing polacrilin potassium-paroxetine
CN106309363A (en) * 2016-09-24 2017-01-11 万特制药(海南)有限公司 Paroxetine hydrochloride oral suspension and preparation method thereof
CN112137970A (en) * 2019-06-28 2020-12-29 北京万全德众医药生物技术有限公司 Paroxetine hydrochloride orally disintegrating tablet and preparation process thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058061T3 (en) * 1985-10-25 1994-11-01 Beecham Group Plc DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
GB9305175D0 (en) * 1993-03-13 1993-04-28 Smithkline Beecham Plc Novel process
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
IT1276160B1 (en) * 1995-11-22 1997-10-27 Recordati Chem Pharm READY-RELEASE ORAL PHARMACEUTICAL COMPOSITIONS FOR EXTEMPORARY SUSPENSIONS
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
GB9700690D0 (en) * 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
AP9901698A0 (en) * 1997-05-29 1999-12-31 Smithkline Beecham Corp Novel process.
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
BR9813808A (en) * 1997-12-19 2002-05-28 Smithkline Beecham Corp Process for producing tablets for dispersion in the bite
DK1047428T3 (en) * 1998-01-21 2007-10-08 Glaxo Group Ltd Use of morpholinol in the treatment of sexual disorders
US6699882B2 (en) * 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
GB9808896D0 (en) * 1998-04-25 1998-06-24 Smithkline Beecham Plc Novel compound
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
US6300343B1 (en) * 1998-06-16 2001-10-09 Smithkline Beecham Corporation Method of treatment
CH689805A8 (en) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it.
US6734213B2 (en) * 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
ES2159260B1 (en) * 1999-06-22 2002-05-01 Smithkline Beechan Plc NEW PAROXETINE METHANOSULPHONATE COMPOSITION
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
GB9923748D0 (en) * 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds

Similar Documents

Publication Publication Date Title
AU2002225855A1 (en) Preparation of nanocrystallites
AU2001268659A1 (en) Water treatment compositions
AU2001242808A1 (en) Water closet
AU2001218090A1 (en) Tissue lockable connecting structures
AUPR105400A0 (en) Processes and compositions for water treatment
AU2001231045A1 (en) Personal cleansing compositions
AU2637801A (en) Methods of forming semiconductor structures
AU2001269331A1 (en) Cleaning and doping of tubulars
AU2001259702A1 (en) Tissue regrafting
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2001249855A1 (en) Aqueous mineral compositions and methods for their use
AU2001241837A1 (en) Processed tissue webs
AU2001232079A1 (en) Water dispersible formulation of paroxetine
AU2001285914A1 (en) Improved swellable phyllosilicates
AU3207901A (en) Water dispersible formulation of paroxetine
AU2001276347A1 (en) Water swellable compositions
AU2001284763A1 (en) Preparation of risperidone
AU2001241771A1 (en) Use of avocado-soybean unsaponifiable preparations
AU2001244108A1 (en) Formulations for states of dehydration
AU2001294062A1 (en) Method of treating aqueous compositions
AU2879801A (en) Effervescent compositions comprising nimesulide
AU2001245950A1 (en) Preparation of deoxynucleosides
AU2001255773A1 (en) Human caspase-14 compositions
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AUPR099200A0 (en) New formulation